About the Funds

In 2021, a nationwide settlement was reached to resolve all opioids litigation brought by states and local political subdivisions against the three largest pharmaceutical distributors, McKesson, Cardinal Health, and AmerisourceBergen (“Distributors”) and against manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson (collectively, “J&J”). These National Settlements have been finalized, and payments have already begun. In all, nationally, the Distributors will pay up to $21 billion over 18 years, and J&J will pay up to an additional $5 billion over no more than nine years.

Georgia and its local governments stand to receive approximately $638 million under the settlement agreement. Georgia’s share of the settlement will be distributed among the state and local governments.  

​​​​ "As part of our commitment to protecting the lives and livelihoods of Georgia citizens, we are dedicated to holding those accountable who have played a critical role in contributing to the opioid epidemic.

 --Attorney General Chris Carr

The Georgia Opioid Crisis Abatement Trust (“Trust”) was created to receive Georgia’s portion of the settlement funds and any interest generated by those funds. State funds received through the settlement will be made available through a competitive application process. More information on that process will be made available on this website at a later date.